💥MEI Pharma: A Quantum Leap in Corporate Finance with #Litecoin

MEI Pharma (MEIP), a bold pharmaceutical company listed on NASDAQ, has rewritten the financial playbook by closing a private placement of $100 million to establish a treasury entirely based on Litecoin ($LTC ). This unprecedented move has not only catapulted its shares by more than 100% in just five days, but it has also injected a palpable confidence into the market, demonstrating the growing appetite for the integration of digital assets in the corporate sphere.

The entirety of the funds will be allocated to the purchase of LTC, positioning MEI Pharma as the first and only public company with Litecoin as its primary reserve asset. With the backing of influential figures like Charlie Lee, creator of Litecoin, who also joins the board of directors and GSR as an advisor, this initiative transcends mere investment. It is a manifesto of the maturity of cryptocurrencies and their potential to redefine traditional treasury strategies.